Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.

HSP72 functionally inhibits the anti-neoplastic effects of HDAC inhibitors.

Fujii K, Suzuki N, Jimura N, Idogawa M, Kondo T, Iwatsuki K, Kanekura T.

J Dermatol Sci. 2018 Apr;90(1):82-89. doi: 10.1016/j.jdermsci.2018.01.002. Epub 2018 Jan 31.

PMID:
29395577
2.

Identification and characterization of a metastatic suppressor BRMS1L as a target gene of p53.

Koyama R, Tamura M, Nakagaki T, Ohashi T, Idogawa M, Suzuki H, Tokino T, Sasaki Y.

Cancer Sci. 2017 Dec;108(12):2413-2421. doi: 10.1111/cas.13420. Epub 2017 Nov 6.

3.

Profiling cancer-related gene mutations in oral squamous cell carcinoma from Japanese patients by targeted amplicon sequencing.

Nakagaki T, Tamura M, Kobashi K, Koyama R, Fukushima H, Ohashi T, Idogawa M, Ogi K, Hiratsuka H, Tokino T, Sasaki Y.

Oncotarget. 2017 Jul 15;8(35):59113-59122. doi: 10.18632/oncotarget.19262. eCollection 2017 Aug 29.

4.

Fledglings in p53 signaling network.

Tokino T, Idogawa M, Sasaki Y.

Oncotarget. 2017 Jul 14;8(34):55768-55769. doi: 10.18632/oncotarget.19229. eCollection 2017 Aug 22. No abstract available.

5.

Long non-coding RNA NEAT1 is a transcriptional target of p53 and modulates p53-induced transactivation and tumor-suppressor function.

Idogawa M, Ohashi T, Sasaki Y, Nakase H, Tokino T.

Int J Cancer. 2017 Jun 15;140(12):2785-2791. doi: 10.1002/ijc.30689. Epub 2017 Mar 27.

6.

p53 mediates the suppression of cancer cell invasion by inducing LIMA1/EPLIN.

Ohashi T, Idogawa M, Sasaki Y, Tokino T.

Cancer Lett. 2017 Apr 1;390:58-66. doi: 10.1016/j.canlet.2016.12.034. Epub 2017 Jan 13.

PMID:
28093207
7.

Identification and characterization of the intercellular adhesion molecule-2 gene as a novel p53 target.

Sasaki Y, Tamura M, Takeda K, Ogi K, Nakagaki T, Koyama R, Idogawa M, Hiratsuka H, Tokino T.

Oncotarget. 2016 Sep 20;7(38):61426-61437. doi: 10.18632/oncotarget.11366.

8.

CRKL oncogene is downregulated by p53 through miR-200s.

Tamura M, Sasaki Y, Kobashi K, Takeda K, Nakagaki T, Idogawa M, Tokino T.

Cancer Sci. 2015 Aug;106(8):1033-40. doi: 10.1111/cas.12713. Epub 2015 Jul 14.

9.

Contextual niche signals towards colorectal tumor progression by mesenchymal stem cell in the mouse xenograft model.

Nakagaki S, Arimura Y, Nagaishi K, Isshiki H, Nasuno M, Watanabe S, Idogawa M, Yamashita K, Naishiro Y, Adachi Y, Suzuki H, Fujimiya M, Imai K, Shinomura Y.

J Gastroenterol. 2015 Sep;50(9):962-74. doi: 10.1007/s00535-015-1049-0. Epub 2015 Feb 14.

PMID:
25680886
10.

Array-based genome-wide RNAi screening to identify shRNAs that enhance p53-related apoptosis in human cancer cells.

Idogawa M, Ohashi T, Sugisaka J, Sasaki Y, Suzuki H, Tokino T.

Oncotarget. 2014 Sep 15;5(17):7540-8.

11.

Mesenchymal stem cells cancel azoxymethane-induced tumor initiation.

Nasuno M, Arimura Y, Nagaishi K, Isshiki H, Onodera K, Nakagaki S, Watanabe S, Idogawa M, Yamashita K, Naishiro Y, Adachi Y, Suzuki H, Fujimiya M, Imai K, Shinomura Y.

Stem Cells. 2014 Apr;32(4):913-25. doi: 10.1002/stem.1594.

12.

Identification and analysis of large intergenic non-coding RNAs regulated by p53 family members through a genome-wide analysis of p53-binding sites.

Idogawa M, Ohashi T, Sasaki Y, Maruyama R, Kashima L, Suzuki H, Tokino T.

Hum Mol Genet. 2014 Jun 1;23(11):2847-57. doi: 10.1093/hmg/ddt673. Epub 2014 Jan 8.

PMID:
24403050
13.

Conditioned mesenchymal stem cells produce pleiotropic gut trophic factors.

Watanabe S, Arimura Y, Nagaishi K, Isshiki H, Onodera K, Nasuno M, Yamashita K, Idogawa M, Naishiro Y, Murata M, Adachi Y, Fujimiya M, Imai K, Shinomura Y.

J Gastroenterol. 2014 Feb;49(2):270-82. doi: 10.1007/s00535-013-0901-3. Epub 2013 Nov 12.

PMID:
24217964
14.

Forkhead transcription factor FOXF1 is a novel target gene of the p53 family and regulates cancer cell migration and invasiveness.

Tamura M, Sasaki Y, Koyama R, Takeda K, Idogawa M, Tokino T.

Oncogene. 2014 Oct 2;33(40):4837-46. doi: 10.1038/onc.2013.427. Epub 2013 Nov 4.

PMID:
24186199
15.

AKR1B10, a transcriptional target of p53, is downregulated in colorectal cancers associated with poor prognosis.

Ohashi T, Idogawa M, Sasaki Y, Suzuki H, Tokino T.

Mol Cancer Res. 2013 Dec;11(12):1554-63. doi: 10.1158/1541-7786.MCR-13-0330-T. Epub 2013 Oct 18.

16.

CLCA2, a target of the p53 family, negatively regulates cancer cell migration and invasion.

Sasaki Y, Koyama R, Maruyama R, Hirano T, Tamura M, Sugisaka J, Suzuki H, Idogawa M, Shinomura Y, Tokino T.

Cancer Biol Ther. 2012 Dec;13(14):1512-21. doi: 10.4161/cbt.22280. Epub 2012 Sep 18.

17.

A novel approach to cancer treatment using structural hybrids of the p53 gene family.

Sasaki Y, Oshima Y, Koyama R, Tamura M, Kashima L, Idogawa M, Yamashita T, Toyota M, Imai K, Shinomura Y, Tokino T.

Cancer Gene Ther. 2012 Nov;19(11):749-56. doi: 10.1038/cgt.2012.51. Epub 2012 Sep 7.

PMID:
22956039
18.

CHFR protein regulates mitotic checkpoint by targeting PARP-1 protein for ubiquitination and degradation.

Kashima L, Idogawa M, Mita H, Shitashige M, Yamada T, Ogi K, Suzuki H, Toyota M, Ariga H, Sasaki Y, Tokino T.

J Biol Chem. 2012 Apr 13;287(16):12975-84. doi: 10.1074/jbc.M111.321828. Epub 2012 Feb 15.

19.

p53 negatively regulates the hepatoma growth factor HDGF.

Sasaki Y, Negishi H, Idogawa M, Yokota I, Koyama R, Kusano M, Suzuki H, Fujita M, Maruyama R, Toyota M, Saito T, Tokino T.

Cancer Res. 2011 Nov 15;71(22):7038-47. doi: 10.1158/0008-5472.CAN-11-1053. Epub 2011 Oct 17.

20.

Identification and characterization of early growth response 2, a zinc-finger transcription factor, as a p53-regulated proapoptotic gene.

Yokota I, Sasaki Y, Kashima L, Idogawa M, Tokino T.

Int J Oncol. 2010 Dec;37(6):1407-16.

PMID:
21042708
21.

A novel method, digital genome scanning detects KRAS gene amplification in gastric cancers: involvement of overexpressed wild-type KRAS in downstream signaling and cancer cell growth.

Mita H, Toyota M, Aoki F, Akashi H, Maruyama R, Sasaki Y, Suzuki H, Idogawa M, Kashima L, Yanagihara K, Fujita M, Hosokawa M, Kusano M, Sabau SV, Tatsumi H, Imai K, Shinomura Y, Tokino T.

BMC Cancer. 2009 Jun 23;9:198. doi: 10.1186/1471-2407-9-198.

22.

A single recombinant adenovirus expressing p53 and p21-targeting artificial microRNAs efficiently induces apoptosis in human cancer cells.

Idogawa M, Sasaki Y, Suzuki H, Mita H, Imai K, Shinomura Y, Tokino T.

Clin Cancer Res. 2009 Jun 1;15(11):3725-32. doi: 10.1158/1078-0432.CCR-08-2396. Epub 2009 May 19.

23.

CHFR, a potential tumor suppressor, downregulates interleukin-8 through the inhibition of NF-kappaB.

Kashima L, Toyota M, Mita H, Suzuki H, Idogawa M, Ogi K, Sasaki Y, Tokino T.

Oncogene. 2009 Jul 23;28(29):2643-53. doi: 10.1038/onc.2009.123. Epub 2009 May 18.

PMID:
19448676
24.

p53 family members regulate the expression of the apolipoprotein D gene.

Sasaki Y, Negishi H, Koyama R, Anbo N, Ohori K, Idogawa M, Mita H, Toyota M, Imai K, Shinomura Y, Tokino T.

J Biol Chem. 2009 Jan 9;284(2):872-83. doi: 10.1074/jbc.M807185200. Epub 2008 Nov 11.

25.

Histone deacetylase inhibitor FK228 enhances adenovirus-mediated p53 family gene therapy in cancer models.

Sasaki Y, Negishi H, Idogawa M, Suzuki H, Mita H, Toyota M, Shinomura Y, Imai K, Tokino T.

Mol Cancer Ther. 2008 Apr;7(4):779-87. doi: 10.1158/1535-7163.MCT-07-0395.

26.

Frequent epigenetic inactivation of DICKKOPF family genes in human gastrointestinal tumors.

Sato H, Suzuki H, Toyota M, Nojima M, Maruyama R, Sasaki S, Takagi H, Sogabe Y, Sasaki Y, Idogawa M, Sonoda T, Mori M, Imai K, Tokino T, Shinomura Y.

Carcinogenesis. 2007 Dec;28(12):2459-66. Epub 2007 Aug 3.

PMID:
17675336
27.

Antitumor effect of adenovirus-mediated p53 family gene transfer on osteosarcoma cell lines.

Oshima Y, Sasaki Y, Negishi H, Idogawa M, Toyota M, Yamashita T, Wada T, Nagoya S, Kawaguchi S, Yamashita T, Tokino T.

Cancer Biol Ther. 2007 Jul;6(7):1058-66.

PMID:
17568187
28.

Involvement of splicing factor-1 in beta-catenin/T-cell factor-4-mediated gene transactivation and pre-mRNA splicing.

Shitashige M, Naishiro Y, Idogawa M, Honda K, Ono M, Hirohashi S, Yamada T.

Gastroenterology. 2007 Mar;132(3):1039-54. Epub 2007 Jan 5.

PMID:
17383426
29.

Ku70 and poly(ADP-ribose) polymerase-1 competitively regulate beta-catenin and T-cell factor-4-mediated gene transactivation: possible linkage of DNA damage recognition and Wnt signaling.

Idogawa M, Masutani M, Shitashige M, Honda K, Tokino T, Shinomura Y, Imai K, Hirohashi S, Yamada T.

Cancer Res. 2007 Feb 1;67(3):911-8.

30.

Beta-catenin interacts with the FUS proto-oncogene product and regulates pre-mRNA splicing.

Sato S, Idogawa M, Honda K, Fujii G, Kawashima H, Takekuma K, Hoshika A, Hirohashi S, Yamada T.

Gastroenterology. 2005 Oct;129(4):1225-36.

PMID:
16230076
31.

E-cadherin regulates the association between beta-catenin and actinin-4.

Hayashida Y, Honda K, Idogawa M, Ino Y, Ono M, Tsuchida A, Aoki T, Hirohashi S, Yamada T.

Cancer Res. 2005 Oct 1;65(19):8836-45.

32.

Poly(ADP-ribose) polymerase-1 is a component of the oncogenic T-cell factor-4/beta-catenin complex.

Idogawa M, Yamada T, Honda K, Sato S, Imai K, Hirohashi S.

Gastroenterology. 2005 Jun;128(7):1919-36.

PMID:
15940627
33.

Morphological and transcriptional responses of untransformed intestinal epithelial cells to an oncogenic beta-catenin protein.

Naishiro Y, Yamada T, Idogawa M, Honda K, Takada M, Kondo T, Imai K, Hirohashi S.

Oncogene. 2005 Apr 28;24(19):3141-53.

PMID:
15735679
34.

Actinin-4 increases cell motility and promotes lymph node metastasis of colorectal cancer.

Honda K, Yamada T, Hayashida Y, Idogawa M, Sato S, Hasegawa F, Ino Y, Ono M, Hirohashi S.

Gastroenterology. 2005 Jan;128(1):51-62.

PMID:
15633123
35.

Alternative splice variant of actinin-4 in small cell lung cancer.

Honda K, Yamada T, Seike M, Hayashida Y, Idogawa M, Kondo T, Ino Y, Hirohashi S.

Oncogene. 2004 Jul 1;23(30):5257-62.

PMID:
15122314
36.

Overexpression of BAD preferentially augments anoikis.

Idogawa M, Adachi M, Minami T, Yasui H, Imai K.

Int J Cancer. 2003 Nov 1;107(2):215-23.

37.

[A case of thymoma and hypogammaglobulinemia (Good's syndrome) with lichen planus].

Idogawa M, Yuji H, Toshiaki H, Tadao I, Kohzoh I.

Nihon Rinsho Meneki Gakkai Kaishi. 1999 Jun;22(3):137-43. Review. Japanese.

PMID:
11126665
38.

[A case of aseptic osteomyelitis with heel ulcer improved by steroid application].

Idogawa M, Takahashi H, Soma T, Mihara M, Mizukoshi T, Murakami R, Sugaya T, Makiguchi Y, Imai K.

Nihon Rinsho Meneki Gakkai Kaishi. 2000 Jun;23(3):200-8. Japanese.

PMID:
10917019
39.

[Extranodal non-Hodgkin's lymphoma associated with systemic bone metastasis and secondary myelofibrosis].

Kasahara K, Takahashi T, Oka T, Yamamoto M, Sirata T, Idogawa M, Naeshiro M, Hayashi T, Adachi M, Hinoda Y, Imai K.

Rinsho Ketsueki. 1998 Dec;39(12):1180-4. Japanese.

PMID:
10028851
40.

[Involvement of protein tyrosine phosphatases in cancer development].

Hinoda Y, Idogawa M, Imai K.

Tanpakushitsu Kakusan Koso. 1998 Jun;43(8 Suppl):1186-92. Review. Japanese. No abstract available.

PMID:
9655978

Supplemental Content

Loading ...
Support Center